Women’s History MonthAmy Reed, physician and patient who “moved mountains” to end widespread use of power morcellationBy The Cancer Letter | March 3, 2021Reed, an anesthesiologist, became the face of a national campaign against power morcellation after she underwent the procedure at Brigham & Women’s Hospital. Her advocacy saved the lives of many women.
UpcomingBook Event: From Shadows to Life: A Biography of the Cancer Survivorship Movement
Can one be too smart? In some disciplines such as physics and mathematics the answer is clearly no. In medicine, the answer is not so clear.
On a visit to Virginia Commonwealth University Massey Cancer Center Feb. 24, first lady Jill Biden issued an unprecedented presidential call to action on reducing health inequities—specifically, cancer disparities—in demonstration of the White House's effort to reach and engage underserved communities.
Five academic cancer centers have formed a unique research alliance, Break Through Cancer, to focus on four cancer types—pancreatic cancer, ovarian cancer, glioblastoma, and acute myelogenous leukemia.
A profound, difficult, seemingly impossible human journey begins with the words, “you have cancer.”
Sometime in 1995, Edith Mitchell, a U.S. Air Force oncologist who at the time served as commander of the 131st Medical Squadron at Lambert-St. Louis International Airport, first heard the name Jane Cooke Wright.
As the Cancer History Project gets underway, our archives are growing. Now featuring past issues of The Cancer Letter from 1973-2014 and The Clinical Cancer Letter from 1977-2014, the database is becoming a fun place to explore. Go ahead, do a search for your mentors, and unearth lost quotes from times passed.
The National Cancer Institute approved the following clinical research studies last month.
FDA has granted accelerated approval to Tepmetko (tepotinib) for adult patients with metastatic non-small cell lung cancer harboring mesenchymal-epithelial transition exon 14 skipping alterations.
